Cargando…
Racial differences as predictors of outcomes in young patients with multiple myeloma
Autores principales: | Bao, Alicia, Zhao, Qiuhong, Merritt, Elizabeth, Bumma, Naresh, Devarakonda, Srinivas, Khan, Abdullah M., Umyarova, Elvira, Rosko, Ashley E., Benson, Don M., Cottini, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329432/ https://www.ncbi.nlm.nih.gov/pubmed/35896527 http://dx.doi.org/10.1038/s41408-022-00708-3 |
Ejemplares similares
-
Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myeloma
por: Khan, Abdullah M., et al.
Publicado: (2023) -
Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma
por: Bao, Alicia, et al.
Publicado: (2023) -
Early versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma
por: Nunnelee, Jordan, et al.
Publicado: (2022) -
Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma
por: Ozga, Michael, et al.
Publicado: (2023) -
Multiple Myeloma: Clinical Updates from the American Society of Clinical Oncology Annual Scientific Symposium 2020
por: Devarakonda, Srinivas, et al.
Publicado: (2020)